Chemoradiotherapy as adjuvant treatment of gastric cancer
Open Access
- 1 June 2007
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 18 (suppl_6) , vi133-vi135
Abstract
Historically, radiotherapy has been occasionally used in the treatment of gastric cancer. More recently, the results of INT-0116 trial have shown an improvement of disease-free and overall survival by chemoradiation with a significant impact on the management of this tumor. Based on these data, there has been an increasing interest in radiotherapy and its association with chemotherapy for patients with locoregional disease as a part of an adjuvant treatment after surgery in high-risk patients. However, many questions remain to evaluate; first of all the toxicity of this approach and its efficacy after adequate surgery.Keywords
This publication has 22 references indexed in Scilit:
- Nodal dissection for patients with gastric cancer: a randomised controlled trialThe Lancet Oncology, 2006
- Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectivesCancer Chemotherapy and Pharmacology, 2004
- The epidemiology of gastric cancerSeminars in Radiation Oncology, 2002
- Gastric cancer—Patterns of relapse after surgical resectionSeminars in Radiation Oncology, 2002
- Extended Lymph-Node Dissection for Gastric CancerNew England Journal of Medicine, 1999
- Should systematic lymph node dissection be recommended for gastric cancer? Pro:European Journal of Cancer, 1998
- A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral CancerAnnals of Surgery, 1994
- A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim reportBritish Journal of Cancer, 1989
- ADJUVANT CHEMOTHERAPY IN OPERABLE GASTRIC CANCERThe Lancet, 1989
- Randomized comparison of R1 and R2 gastrectomy for gastric carcinomaBritish Journal of Surgery, 1988